Checking blood sugar test accuracy for arthritis patients on sulfasalazine
Part of Bones, joints & muscles, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study checks if the medicine sulfasalazine affects a blood sugar test (HbA1c) in people with inflammatory arthritis. If you have arthritis, take sulfasalazine, and have higher blood sugar or diabetes, this trial may help understand your glucose levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been taking the medicine sulfasalazine for at least 2 months.
- You have a type of inflammatory arthritis (such as rheumatoid arthritis, reactive arthritis, ankylosing spondylitis, psoriatic arthritis, or juvenile arthritis).
- Either your HbA1c (a blood sugar test) is at least 38 mmol/mol, or you have been diagnosed with diabetes (type 1, type 2, or another type).
- You can speak Danish and agree to upload your glucose information to a secure platform (Libreview).
- You have not had steroid injections or high-dose steroid pills in the last 2 months and do not plan to in the next 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special skin scanner to measure sugar-related damage in the body, which may be linked to inflammation. It compares people with rheumatic conditions to healthy volunteers to see if the scanner can help track or predict disease.
This study looks at how well blood sugar is controlled in people who have both type 2 diabetes and rheumatoid arthritis. The goal is to see if better blood sugar control can help reduce rheumatoid arthritis symptoms.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This trial is checking how well blood sugar is controlled in adults recently diagnosed with type 2 diabetes (within the last 3 months). It aims to see if current treatments or lifestyle changes are working and may help guide future care.
This study tests whether two diabetes medications, dapagliflozin and empagliflozin, can help reduce rheumatoid arthritis symptoms when added to your current methotrexate treatment. It may offer a new option for people whose arthritis is still active despite methotrexate.
This trial checks if treating advanced gum disease at a specialist clinic can help find hidden high blood sugar and support you in managing your overall health.
Hear when a new Inflammatory Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.